Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 350,000,000
    Countries
    Sector(s)
    Belgium : € 350,000,000
    Industry : € 350,000,000
    Signature date(s)
    18/11/2021 : € 350,000,000

    Summary sheet

    Release date
    21 March 2022
    Status
    Reference
    Signed | 18/11/2021
    20200708
    Project name
    Promoter - financial intermediary
    UCB INFLEXIO NEW MANUFACTURING PLANT AND R&D
    UCB SA
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 350 million
    EUR 975 million
    Location
    Sector(s)
    Description
    Objectives

    The project concerns investments in research and development (R&D) activities and in the construction of an advanced manufacturing plant that will be located in existing promoter facilities in Belgium.

    The project aims at improving the health of European citizens, increasing the competitiveness and boosting the innovative capacity of European health-related industries and businesses. The project focuses on neuroscience and immunology in particular neuro-degeneration, neuro-inflammation and rare diseases as well as autoimmune diseases, which are mostly still underserved and leave a high clinical unmet need.

    Environmental aspects
    Procurement

    The project includes the construction of a new plant to manufacture pharmaceutical products. This activity is listed in the Annex II of the Environmental Impact Assessment (EIA) Directive. Whether a EIA under the directive 2014/52/EU is required and other environmental details will be verified during the project appraisal.

    The Promoter is a private company not operating in the Utilities sector and not having a status of a contracting entity. Thus it is not covered by EU Directives on procurement.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - UCB INFLEXIO NEW MANUFACTURING PLANT AND R&D
    Publication Date
    25 Mar 2022
    Document language
    Main Topic
    Lending
    Document Number
    141153635
    Document Focus
    Environmental Information
    Project Number
    20200708
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications